Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA3 | P07451 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21373956 | 0.83 | ALDH1A1 (0.38) | TDP1CA12CA1CA2CA3 | |
| SCHEMBL28292932 | 0.82 | TDP1 (0.40) | TDP1 | |
| SCHEMBL7900784 | 0.79 | TDP1 (0.38) | TDP1 | |
| SCHEMBL19917421 | 0.79 | TDP1 (0.38) | TDP1 | |
| SCHEMBL19822064 | 0.76 | CA12 (0.41) | CA12CA1CA2CA3CA4 | |
| SCHEMBL15593349 | 0.76 | — | — | |
| SCHEMBL8785000 | 0.76 | — | — | |
| SCHEMBL19821869 | 0.74 | EPHX2 (0.34) | CA12CA1CA2CA3CA4 | |
| SCHEMBL19822062 | 0.73 | CYP1A2 (0.53) | CA12CA1CA2CA3CA4 | |
| SCHEMBL26412892 | 0.73 | ALDH1A1 (0.35) | TDP1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109651286-B | High-selectivity synthesis method of 4- (4-aminophenyl) morpholine-3-one | 新发药业有限公司 | 2020-08-11 | — | — | CN | disclosed |